Samsung Biologics wins $1.24 bn deal for contract manufacturing
SEOUL: Samsung Biologics on Tuesday said it has signed a deal worth $1.24 billion for contract manufacturing from an Asia-based biopharmaceutical firm.
The deal will last until the end of 2037, the company said in a regulatory filing.…